BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31736229)

  • 1. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
    Tas ML; Nagtegaal M; Kraal KCJM; Tytgat GAM; Abeling NGGM; Koster J; Pluijm SMF; Zwaan CM; de Keizer B; Molenaar JJ; van Noesel MM
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28061. PubMed ID: 31736229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
    Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
    J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
    Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
    Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital stage 1 neuroblastoma evolved into stage 4s.
    Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watch and See Strategy in Selected Neuroblastoma Case Scenarios: Success and Limitations.
    Fawzy M; El Zomor H; El Menawi S; Elkinaai N; Ahmed G; Refaat A; Elahmadawy M; Zaghloul M
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e384-e387. PubMed ID: 30676440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
    Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
    Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
    Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
    J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
    Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
    J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry.
    Parodi S; Sorrentino S; Cataldo AD; Tondo A; Fagnani AM; Perri P; Gigliotti AR; Erminio G; Corrias MV; De Bernardi B
    Pediatr Blood Cancer; 2021 May; 68(5):e28904. PubMed ID: 33459514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aggressive local treatment necessary for diffuse liver involvement in patients with progression of stage 4s neuroblastoma to stage 4?
    Heij HA; Verschuur AC; Kaspers GJ; van Rijn RR; Adam JA; Aronson DC
    J Pediatr Surg; 2008 Sep; 43(9):1630-5. PubMed ID: 18778997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
    Noguera R; Cañete A; Pellín A; Ruiz A; Tasso M; Navarro S; Castel V; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jan; 140(2):157-61. PubMed ID: 12645655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connatal localized neuroblastoma. The case to delay treatment.
    Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
    Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
    De Bernardi B; Gerrard M; Boni L; Rubie H; Cañete A; Di Cataldo A; Castel V; Forjaz de Lacerda A; Ladenstein R; Ruud E; Brichard B; Couturier J; Ellershaw C; Munzer C; Bruzzi P; Michon J; Pearson AD
    J Clin Oncol; 2009 Mar; 27(7):1034-40. PubMed ID: 19171711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
    Mubarak M; Singal AK; Gawdi A
    Gulf J Oncolog; 2019 May; 1(30):81-84. PubMed ID: 31242987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
    Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.